BESHAR LUKE M 4

What Happened

• Luke M. Beshar, a member of Protara Therapeutics' (TARA) board of directors, received an equity award of 31,000 shares on June 15, 2026. The award was reported as a derivative grant at $0.00 per share (total reported value $0), classified as an "A" (award/grant) transaction.

Key Details

• Transaction date: 2026-06-15; filing date: 2026-06-16 (timely).
• Transaction type: Award/Grant (derivative), 31,000 shares, $0.00 per share.
• Shares owned after transaction: Not reported in the provided excerpt of the Form 4.
• Footnote: The shares subject to the annual grant vest in full on the first anniversary of the grant date, contingent on continuous board service, and will vest in full upon a Change of Control.
• No sale, purchase for cash, option exercise, tax withholding, or 10b5-1 plan was indicated.

Context

• This is a standard director equity award, commonly used to compensate board members. It is not a market purchase or sale and does not by itself indicate buying or selling sentiment. The award vests after one year of continuous service (or sooner on a change of control), so the recipient does not have immediate free-trading shares.